Storage of glycogen is essential for glucose homeostasis and for energy supply during bursts of activity and sustained muscle work. We describe three siblings with profound muscle and heart ...

Proteins (blue lettering) involved in glycogen storage diseases (GSDs ... the Howard Hughes Medical Institute and by the National Heart, Lung, and Blood Institute, National Institutes of Health.

Glycogen storage disease (GSD ... A 24-h Holter-ECG recording did not show any heart rhythm disorder. As the sister's condition worsened quickly under high-carbohydrate diet, we hypothesized ...

Boston, MA - A syndrome that included exercise intolerance and a kind of hypertrophic cardiomyopathy was identified in several children in a family of Syrian descent, many of whom were ultimately ...

Glycogen storage disease (GSD) refers to a group of rare genetic conditions that affect how the body stores and breaks down glycogen. The most common type is type I, also called von Gierke disease.

About three-quarters of your glycogen is found in your muscles. The storage process (glycogenesis) is activated by a hormone called insulin. Your pancreas releases insulin as glucose levels rise ...

Glycogen is the stored form of glucose. Your body makes sure that glucose is always available when you need it. Our body uses glucose to fuel all the cells in the body. Our muscles, heart ...

Most of us will someday have conditions that are common — cancer, diabetes, heart disease — diseases ... other people in the world, has a glycogen storage disease. He has the most common ...

Glycogen storage disease type III (GSD III ... skeletal muscle, and heart. Research in this field has advanced our understanding of the molecular basis of the disease, improved diagnostic accuracy ...

Glycogen storage disease stops the body from being ... But it can be very damaging to their liver and to their heart." Rodd says that now that the gene has been identified, Nunavik communities ...

Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Glycogen Storage Disease (GSD) Type 1a Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access ...